Intratypic variants of human papillomavirus type 16 and risk of cervical Neoplasia in Taiwan

Journal of Medical Virology

Volumn 85, Issue 9, 2013, Pages 1567-1576

  Chang, Ya Ju ^a   Chen, Hui Chi ^b   Pan, Mei Hung ^b   Lee, Bor Heng ^c   You, San Lin ^b   Lin, Ching Yu ^d   Chou, Yi Chun ^a   Hsieh, Chang Yao ^e   Cheng, Yu Juen ^a   Liaw, Kai Li ^f   Hsing, Ann W ^g   Schiffman, Mark ^g   Chen, Chien Jen ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c King Car Food Industrial Co Ltd   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f MERCK RESEARCH LABORATORIES   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical neoplasia; HPV 16; Prevalence; Taiwan; Variants

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; TISSUE SECTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS GENE;

CERVICAL NEOPLASIA; HPV 16; PREVALENCE; TAIWAN; VARIANTS;

ADULT; AGED; DNA, VIRAL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; POINT MUTATION; REPRESSOR PROTEINS; RISK ASSESSMENT; SEQUENCE ANALYSIS, DNA; TAIWAN; UTERINE CERVICAL NEOPLASMS;

EID: 84880358680     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23651     Document Type: Article

References (44)

1. Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, Tommasino M, Zehbe I, Sherman L. 2007. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol 79:1751-1760.
2. Berumen J, Ordonez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A, Gonzalez-Lira G, Madrigal-de la Campa A. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: A case-control study. J Natl Cancer Inst 93:1325-1330.
3. Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, Sinnott P, Stern PL. 1998. HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 78:166-171.
4. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens-Part B: Biological agents. Lancet Oncol 10:321-322.
5. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, Stanley MA, Krishna S. 2004. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 78:5934-5945.
6. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Xu LY, Cheng AF. 2002. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 186:696-700.
7. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, Burk RD. 2005. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 79:7014-7023.
8. Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, Hsieh CY, Liaw KL, Hsing AW, Chen CJ. 2011a. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst 103:1387-1396.
9. Chen HC, You SL, Hsieh CY, Schiffman M, Lin CY, Pan MH, Chou YC, Liaw KL, Hsing AW, Chen CJ. 2011b. Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: A community-based survey of 10, 602 women. Int J Cancer 128:1192-1203.
10. Choi BS, Kim SS, Yun H, Jang DH, Lee JS. 2007. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. J Med Virol 79:426-430.
11. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
12. Ding T, Wang X, Ye F, Cheng X, Lu W, Xie X. 2010. Distribution of human papillomavirus 16 E6/E7 variants in cervical cancer and intraepithelial neoplasia in Chinese women. Int J Gynecol Cancer 20:1391-1398.
13. Giannoudis A, Herrington CS. 2001. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193:295-302.
14. Grodzki M, Besson G, Clavel C, Arslan A, Franceschi S, Birembaut P, Tommasino M, Zehbe I. 2006. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15:820-822.
15. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
16. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, Kahn T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, Norrild B, Radhakrishna PM, Stoerker J, Syrjaenen K, Syrjaenen S, Tay SK, Villa LL, Wheeler CM, Williamson AL, Bernard HU. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
17. Kammer C, Tommasino M, Syrjanen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe I. 2002. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: Implications for cervical disease. Br J Cancer 86:269-273.
18. Kang S, Jeon YT, Kim JW, Park NH, Song YS, Kang SB, Lee HP. 2005. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 15:107-112.
19. Lasken RS, Egholm M. 2003. Whole genome amplification: Abundant supplies of DNA from precious samples or clinical specimens. Trends Biotechnol 21:531-535.
20. Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, Tommasino M, Zehbe I, Sherman L. 2006. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 350:216-227.
21. Lin CY, Chen HC, Lin RW, You SL, You CM, Chuang LC, Pan MH, Lee MH, Choub YC, Chen CJ. 2007. Quality assurance of genotyping array for detection and typing of human papillomavirus. J Virol Methods 140:1-9.
22. Lin CY, Chao A, Yang YC, Chou HH, Ho CM, Lin RW, Chang TC, Chiou JY, Chao FY, Wang KL, Chien TY, Hsueh S, Huang CC, Chen CJ, Lai CH. 2008. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 42:361-367.
23. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364-368.
24. Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, Kawana K, Sekiya S, Hirai Y, Kukimoto I, Kanda T, Taketani Y. 2000. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156:159-165.
25. Munoz N, Bosch FX, Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders JF, Meijer JLM. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
26. Myers G, Delius H, Icenogle J, Bernard HU, Favre M, van Ranst M, Wheeler CM. 1997. Human papillomaviruses 1997: A compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N Mex.
27. Nindl I, Rindfleisch K, Teller K, Schneider A, Durst M. 1999. Cervical cancer, HPV 16 E6, variant genotypes, and serology. Lancet 353:152.
28. Peters GA, Tyler SD, Grose C, Severini A, Gray MJ, Upton C, Tipples GA. 2006. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol 80:9850-9860.
29. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD. 2010. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70:3159-3169.
30. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
31. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL. 2007. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer 120:1763-1768.
32. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH, Lee HP. 1997. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 66:275-281.
33. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74:117-126.
34. Vaeteewoottacharn K, Jearanaikoon P, Ponglikitmongkol M. 2003. Comutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. Anticancer Res 23:1927-1931.
35. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
36. Wu Y, Chen Y, Li L, Yu G, He Y, Zhang Y. 2006. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol 87:1181-1188.
37. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
38. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, Ho J, Kiviat NB. 2007. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev 16:4-10.
39. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol 71:2463-2472.
40. Zanier K, ould M'hamed Ould Sidi A, Boulade-Ladame C, Rybin V, Chappelle A, Atkinson A, Kieffer B, Trave G. 2012. Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53. Structure 20:604-617.
41. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. 1998a. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
42. Zehbe I, Wilander E, Delius H, Tommasino M. 1998b. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.
43. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. 2001. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94:711-716.
44. Zehbe I, Richard C, DeCarlo CA, Shai A, Lambert PF, Lichtig H, Tommasino M, Sherman L. 2009. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 383:69-77.